Early use of erenumab in US real-world practice

Early use of erenumab in US real-world practice

Background: Erenumab, a monoclonal antibody (mAb) developed to block the calcitonin gene-related peptide (CGRP) receptor, is approved for the prevention of migraine in adults. This retrospective observational study sought to describe early real-world use of erenumab. Methods: This study used the Pra...

Full description

Saved in:
Bibliographic Details
Main Authors: Alina Bogdanov (Author), Victoria Chia (Author), Mark Bensink (Author), Robert Urman (Author), Lauren Fischer (Author), Soeren Rasmussen (Author), Christine Szekely (Author), Lee Kallenbach (Author)
Format: Book
Published: SAGE Publishing, 2021-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items